- Home
- A-Z Publications
- Current Drug Metabolism
- Previous Issues
- Volume 18, Issue 6, 2017
Current Drug Metabolism - Volume 18, Issue 6, 2017
Volume 18, Issue 6, 2017
-
-
CORAL Software: Analysis of Impacts of Pharmaceutical Agents Upon Metabolism via the Optimal Descriptors
Authors: Mariya A. Toropova, Ivan Raska Jr, Alla P. Toporova and Maria RaskovaBackgrounds: The CORAL software has been developed as a tool to build up quantitative structure-activity relationships (QSAR) for various endpoints. Objective: The task of the present work was to estimate and to compare QSAR models for biochemical activity of various therapeutic agents, which are built up by the CORAL software. Method: The Monte Carlo technique gives possibility to build up predictive model of an Read More
-
-
-
Quantum Mechanical (QM) Calculations Applied to ADMET Drug Prediction: A Review
Authors: E. F. Silva-Júnior, T. M. Aquino and J. X. Araujo-JuniorThe discovery of new drugs is generally considered a long and expensive process, which often leads to molecules with low efficacy and high toxicity, which in many cases can be related to metabolism. In an attempt to reduce these failures and the production costs of a new drug, in silico studies have been used to obtain important information about the behavior of these compounds in the metabolism phases: absorption, Read More
-
-
-
Helix-Coil Transition Signatures B-Raf V600E Mutation and Virtual Screening for Inhibitors Directed Against Mutant B-Raf
Background: Mutation in the B RAF at V600E has been well implicated in the carcinogenesis that makes it as an attractive therapeutictarget. In the present study, we sought to identify the basis of V600E mutation at functional and structural grounds. The study also endeavors in identification of small molecule as a potential candidate with considerable pharmacological profile than available BRAF inhibitors through computational Read More
-
-
-
In-silico ADME Studies for New Drug Discovery: From Chemical Compounds to Chinese Herbal Medicines
Authors: Guojun Yan, Xiaobing Wang, Zhou Chen, Xianhui Wu, Jinhuo Pan, Yushen Huang, Gang Wan and Zhaogang YangNowadays, in silico tools are widely used to provide the potential structure of the metabolites formed depending on the site of metabolism. These methods can also highlight the molecular moieties that help to direct the molecule into the cytochrome cavity so that the site of metabolism is in proximity to the catalytic center. In this minireview, we summarized three aspects of the in silico methods in the application of predictio Read More
-
-
-
Towards Predicting the Cytochrome P450 Modulation: From QSAR to Proteochemometric Modeling
Drug metabolism determines the fate of a drug when it enters the human body and is a critical factor in defining their absorption, distribution, metabolism, excretion and toxicity (ADMET) characteristics. Among the various drug metabolizing enzymes, cytochrome P450s (CYP450) constitute an important protein family that aside from functioning in xenobiotic metabolism, is also responsible for a diverse array of other roles e Read More
-
-
-
Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools
Authors: Naiem T. Issa, Henri Wathieu, Abiola Ojo, Stephen W. Byers and Sivanesan DakshanamurthyBackground: While establishing efficacy in translational models and humans through clinically-relevant endpoints for disease is of great interest, assessing the potential toxicity of a putative therapeutic drug is critical. Toxicological assessments in the pre-clinical discovery phase help to avoid future failure in the clinical phases of drug development. Many in vitro assays exist to aid in modular toxicological assessment, such as h Read More
-
-
-
In silico and In vivo Toxicological Evaluation of Cissampelos Sympodialis Secondary Metabolites in Rattus Norvegicus
Authors: Mateus F. Alves, Marcus T. Scotti, Mayara B. Felix, Hamilton M. Ishiki, Cinthia Rodrigues Melo, Frederico F. Ribeiro, Josean F. Tavares, Jose M.B. Filho, Kardilandia M. de Oliveira, Andrea F. R. de Paula, Francisco J. B. Mendonca Jr., Luciana Scotti, Alexandre R. da Paz, Socrates G. dos Santos and Margareth de F. F. M. DinizCissampelos sympodialis is a plant in northeastern Brazil used by the populace for treating respiratory diseases. Several studies have shown that ethanol leaf extracts have immunomodulatory and anti-inflammatory activities. Infusions are widely used, popular, and an ancient technique in traditional medicine, using hot water alone as the means of extraction. This study aimed to investigate acute toxicological potential of le Read More
-
-
-
In-silico Design and ADMET Studies of Natural Compounds as Inhibitors of Xanthine Oxidase (XO) Enzyme
Authors: Neelam Malik, Priyanka Dhiman and Anurag KhatkarBackground: Xanthine oxidase a ubiquitous enzyme has been found to be involved in various pathological disorders including gout, hyperuricemia, inflammation, oxidative stress and cardiovascular diseases. Inhibitors of xanthine oxidase thus find a crucial role in the therapeutic treatment of these deadly diseases. Objective: Considering the side effects of today's treatment regimen here we choose nature based compounds t Read More
-
Volumes & issues
-
Volume 25 (2024)
-
Volume 24 (2023)
-
Volume 23 (2022)
-
Volume 22 (2021)
-
Volume 21 (2020)
-
Volume 20 (2019)
-
Volume 19 (2018)
-
Volume 18 (2017)
-
Volume 17 (2016)
-
Volume 16 (2015)
-
Volume 15 (2014)
-
Volume 14 (2013)
-
Volume 13 (2012)
-
Volume 12 (2011)
-
Volume 11 (2010)
-
Volume 10 (2009)
-
Volume 9 (2008)
-
Volume 8 (2007)
-
Volume 7 (2006)
-
Volume 6 (2005)
-
Volume 5 (2004)
-
Volume 4 (2003)
-
Volume 3 (2002)
-
Volume 2 (2001)
-
Volume 1 (2000)
Most Read This Month
Article
content/journals/cdm
Journal
10
5
false
en
